Victory Capital Management Inc Blueprint Medicines Corp Transaction History

Victory Capital Management Inc

  • $98.4 Billion
  • Q1 2024

A detailed history of Victory Capital Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 206,199 shares of BPMC stock, worth $22.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
206,199
Previous 131,050 57.34%
Holding current value
$22.2 Million
Previous $12.1 Million 61.81%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$73.17 - $99.79 $5.5 Million - $7.5 Million
75,149 Added 57.34%
206,199 $19.6 Million
Q4 2023

Feb 05, 2024
BUY
$43.96 - $92.84 $5.47 Million - $11.6 Million
124,517 Added 1905.97%
131,050 $12.1 Million
Q3 2023

Nov 06, 2023
BUY
$46.9 - $66.0 $4,455 - $6,270
95 Added 1.48%
6,533 $328,000
Q2 2023

Jul 27, 2023
SELL
$42.2 - $66.37 $6,287 - $9,889
-149 Reduced 2.26%
6,438 $406,000
Q1 2023

May 02, 2023
BUY
$37.97 - $50.0 $493 - $650
13 Added 0.2%
6,587 $296,000
Q4 2022

Feb 10, 2023
BUY
$41.06 - $66.48 $2,422 - $3,922
59 Added 0.91%
6,574 $288,000
Q4 2022

Feb 09, 2023
SELL
$41.06 - $66.48 $474,201 - $767,777
-11,549 Reduced 63.93%
6,515 $285,000
Q3 2022

Nov 02, 2022
BUY
$49.93 - $77.7 $575,942 - $896,269
11,535 Added 176.67%
18,064 $1.19 Million
Q2 2022

Aug 01, 2022
SELL
$45.23 - $70.15 $30,485 - $47,281
-674 Reduced 9.36%
6,529 $330,000
Q1 2022

May 04, 2022
SELL
$54.1 - $110.08 $21.3 Million - $43.3 Million
-393,039 Reduced 98.2%
7,203 $420,000
Q4 2021

Feb 07, 2022
BUY
$94.25 - $115.99 $37.1 Million - $45.6 Million
393,124 Added 5522.96%
400,242 $42.9 Million
Q3 2021

Nov 02, 2021
SELL
$80.98 - $109.47 $42.2 Million - $57.1 Million
-521,336 Reduced 98.65%
7,118 $732,000
Q2 2021

Aug 03, 2021
BUY
$82.78 - $101.0 $5.45 Million - $6.65 Million
65,797 Added 14.22%
528,454 $46.5 Million
Q1 2021

May 04, 2021
SELL
$90.71 - $108.28 $1.98 Million - $2.36 Million
-21,841 Reduced 4.51%
462,657 $45 Million
Q4 2020

Feb 01, 2021
SELL
$92.08 - $124.48 $12.3 Million - $16.7 Million
-133,903 Reduced 21.65%
484,498 $54.3 Million
Q3 2020

Nov 09, 2020
BUY
$66.45 - $92.7 $3.58 Million - $4.99 Million
53,880 Added 9.54%
618,401 $57.3 Million
Q2 2020

Aug 07, 2020
SELL
$57.09 - $79.27 $5.69 Million - $7.9 Million
-99,600 Reduced 15.0%
564,521 $44 Million
Q1 2020

May 04, 2020
BUY
$48.11 - $82.22 $4.95 Million - $8.46 Million
102,939 Added 18.34%
664,121 $38.8 Million
Q4 2019

Feb 06, 2020
SELL
$66.73 - $82.59 $249,370 - $308,638
-3,737 Reduced 0.66%
561,182 $45 Million
Q4 2019

Feb 04, 2020
SELL
$66.73 - $82.59 $4.94 Million - $6.11 Million
-73,993 Reduced 11.58%
564,919 $35.8 Million
Q3 2019

Nov 12, 2019
BUY
$72.9 - $101.41 $10.7 Million - $14.9 Million
147,010 Added 29.89%
638,912 $46.9 Million
Q2 2019

Aug 15, 2019
BUY
$73.54 - $97.8 $1.44 Million - $1.92 Million
19,620 Added 4.15%
491,902 $46.4 Million
Q1 2019

May 03, 2019
BUY
$48.7 - $86.6 $103,244 - $183,592
2,120 Added 0.45%
472,282 $37.8 Million
Q4 2018

Feb 05, 2019
BUY
$45.57 - $74.26 $710,892 - $1.16 Million
15,600 Added 3.43%
470,162 $25.3 Million
Q3 2018

Nov 01, 2018
BUY
$58.91 - $78.32 $888,362 - $1.18 Million
15,080 Added 3.43%
454,562 $35.5 Million
Q2 2018

Aug 02, 2018
SELL
$60.96 - $101.18 $1.79 Million - $2.97 Million
-29,320 Reduced 6.25%
439,482 $27.9 Million
Q1 2018

May 04, 2018
SELL
$73.28 - $102.95 $627,276 - $881,252
-8,560 Reduced 1.79%
468,802 $43 Million
Q4 2017

Feb 01, 2018
BUY
$62.91 - $88.32 $3.74 Million - $5.26 Million
59,500 Added 14.24%
477,362 $36 Million
Q3 2017

Oct 27, 2017
SELL
$42.37 - $69.67 $7.17 Million - $11.8 Million
-169,190 Reduced 28.82%
417,862 $29.1 Million
Q2 2017

Aug 07, 2017
BUY
N/A
587,052
587,052 $29.7 Million

Others Institutions Holding BPMC

# of Institutions
313
Shares Held
60.6M
Call Options Held
634K
Put Options Held
691K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.44B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email